RU2013107451A - Комбинация силоксана и активного ингредиента для лечения стоматологических заболеваний - Google Patents
Комбинация силоксана и активного ингредиента для лечения стоматологических заболеваний Download PDFInfo
- Publication number
- RU2013107451A RU2013107451A RU2013107451/04A RU2013107451A RU2013107451A RU 2013107451 A RU2013107451 A RU 2013107451A RU 2013107451/04 A RU2013107451/04 A RU 2013107451/04A RU 2013107451 A RU2013107451 A RU 2013107451A RU 2013107451 A RU2013107451 A RU 2013107451A
- Authority
- RU
- Russia
- Prior art keywords
- composition
- active ingredient
- pharmacologically active
- composition according
- antibiotic
- Prior art date
Links
- 208000014151 Stomatognathic disease Diseases 0.000 title claims abstract 4
- -1 SILOXAN Chemical class 0.000 title 1
- 239000004480 active ingredient Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 claims abstract 30
- 239000002831 pharmacologic agent Substances 0.000 claims abstract 17
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 claims abstract 9
- 230000003115 biocidal effect Effects 0.000 claims abstract 8
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract 7
- 208000018035 Dental disease Diseases 0.000 claims abstract 3
- 239000003242 anti bacterial agent Substances 0.000 claims abstract 2
- 229960003722 doxycycline Drugs 0.000 claims abstract 2
- XQTWDDCIUJNLTR-CVHRZJFOSA-N doxycycline monohydrate Chemical compound O.O=C1C2=C(O)C=CC=C2[C@H](C)[C@@H]2C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]1[C@H]2O XQTWDDCIUJNLTR-CVHRZJFOSA-N 0.000 claims abstract 2
- 229940124307 fluoroquinolone Drugs 0.000 claims abstract 2
- 239000002271 gyrase inhibitor Substances 0.000 claims abstract 2
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical group C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 claims abstract 2
- 230000035515 penetration Effects 0.000 claims abstract 2
- 230000002265 prevention Effects 0.000 claims abstract 2
- 208000002925 dental caries Diseases 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 239000002552 dosage form Substances 0.000 claims 1
- 229960004023 minocycline Drugs 0.000 claims 1
- DYKFCLLONBREIL-KVUCHLLUSA-N minocycline Chemical compound C([C@H]1C2)C3=C(N(C)C)C=CC(O)=C3C(=O)C1=C(O)[C@@]1(O)[C@@H]2[C@H](N(C)C)C(O)=C(C(N)=O)C1=O DYKFCLLONBREIL-KVUCHLLUSA-N 0.000 claims 1
- FABPRXSRWADJSP-MEDUHNTESA-N moxifloxacin Chemical compound COC1=C(N2C[C@H]3NCCC[C@H]3C2)C(F)=CC(C(C(C(O)=O)=C2)=O)=C1N2C1CC1 FABPRXSRWADJSP-MEDUHNTESA-N 0.000 claims 1
- 229960003702 moxifloxacin Drugs 0.000 claims 1
- 208000028169 periodontal disease Diseases 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/695—Silicon compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/50—Preparations specially adapted for dental root treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/60—Preparations for dentistry comprising organic or organo-metallic additives
- A61K6/69—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Dental Preparations (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10007536.5 | 2010-07-21 | ||
| EP10007536A EP2409702A1 (en) | 2010-07-21 | 2010-07-21 | Combination of siloxane and active ingredient for treating dental disorder of hard tissues |
| PCT/EP2011/061953 WO2012010478A1 (en) | 2010-07-21 | 2011-07-13 | Combination of siloxane and active ingredient for treating dental disorder |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2013107451A true RU2013107451A (ru) | 2014-08-27 |
Family
ID=43038027
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2013107451/04A RU2013107451A (ru) | 2010-07-21 | 2011-07-13 | Комбинация силоксана и активного ингредиента для лечения стоматологических заболеваний |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20130184239A1 (cg-RX-API-DMAC7.html) |
| EP (2) | EP2409702A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2013531048A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20130043203A (cg-RX-API-DMAC7.html) |
| CN (1) | CN103096890A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2011281719A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112013001492A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2805980A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2013000800A (cg-RX-API-DMAC7.html) |
| RU (1) | RU2013107451A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2012010478A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2699371C1 (ru) * | 2018-12-06 | 2019-09-05 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Кубанский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО КубГМУ Минздрава России) | Стоматологическая паста для временного пломбирования каналов корней зубов при лечении хронического деструктивного периодонтита |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH11180841A (ja) * | 1997-12-15 | 1999-07-06 | Lion Corp | 口腔用組成物 |
| DE19962470A1 (de) | 1999-12-22 | 2001-07-12 | Schulz Hans Herrmann | Verwendung von Chemotherapeutika |
| JP2001354535A (ja) * | 2000-06-13 | 2001-12-25 | Lion Corp | 口腔用組成物 |
| JP2002179569A (ja) | 2000-12-12 | 2002-06-26 | Lion Corp | 口腔用組成物 |
| EP1472263B1 (de) | 2001-11-13 | 2006-08-30 | GE Bayer Silicones GmbH & Co. KG | Verwendung von siloxanen als verdampfbare träger |
| EP1443892B1 (en) | 2001-11-15 | 2009-06-10 | Laboratorios Miret, S.A. | Use of cationic surfactant as antimicrobial activity enhancer in deodorants and oral care |
| JP2004107310A (ja) * | 2002-09-13 | 2004-04-08 | Lion Corp | 口腔用組成物 |
| WO2007013175A1 (ja) | 2005-07-29 | 2007-02-01 | Takeshi Tanaka | 歯用漂白剤 |
| GB0518769D0 (en) | 2005-09-14 | 2005-10-19 | Medpharm Ltd | Topical formulations |
-
2010
- 2010-07-21 EP EP10007536A patent/EP2409702A1/en not_active Withdrawn
-
2011
- 2011-07-13 CA CA2805980A patent/CA2805980A1/en not_active Abandoned
- 2011-07-13 BR BR112013001492A patent/BR112013001492A2/pt not_active IP Right Cessation
- 2011-07-13 WO PCT/EP2011/061953 patent/WO2012010478A1/en not_active Ceased
- 2011-07-13 EP EP11730703.3A patent/EP2595626A1/en not_active Withdrawn
- 2011-07-13 RU RU2013107451/04A patent/RU2013107451A/ru not_active Application Discontinuation
- 2011-07-13 US US13/811,140 patent/US20130184239A1/en not_active Abandoned
- 2011-07-13 AU AU2011281719A patent/AU2011281719A1/en not_active Abandoned
- 2011-07-13 CN CN2011800454969A patent/CN103096890A/zh active Pending
- 2011-07-13 JP JP2013520068A patent/JP2013531048A/ja active Pending
- 2011-07-13 MX MX2013000800A patent/MX2013000800A/es not_active Application Discontinuation
- 2011-07-13 KR KR1020137004211A patent/KR20130043203A/ko not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| AU2011281719A1 (en) | 2013-02-21 |
| EP2595626A1 (en) | 2013-05-29 |
| JP2013531048A (ja) | 2013-08-01 |
| US20130184239A1 (en) | 2013-07-18 |
| BR112013001492A2 (pt) | 2016-05-31 |
| KR20130043203A (ko) | 2013-04-29 |
| CN103096890A (zh) | 2013-05-08 |
| WO2012010478A1 (en) | 2012-01-26 |
| EP2409702A1 (en) | 2012-01-25 |
| CA2805980A1 (en) | 2012-01-26 |
| MX2013000800A (es) | 2013-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2012146986A (ru) | Цефемовые соединения, содержащие катехольную группу | |
| MY151430A (en) | Anti-caries oral care compositions with xylitol | |
| RU2014141362A (ru) | Комбинированная терапия пролиферативных нарушений | |
| EA200700099A1 (ru) | Производные пиридина | |
| EA201201414A8 (ru) | КОМБИНАЦИИ, СОДЕРЖАЩИЕ ЗАМЕЩЕННЫЕ 2,3-ДИГИДРОИМИДАЗО[1,2-c]ХИНАЗОЛИНЫ | |
| BR112014019478A2 (pt) | composto ou um sal farmacologicamente aceitável do mesmo, composição farmacêutica, uso de um composto ou de um sal farmacologicamente aceitável do mesmo, formulação inibidor do canal de sódio, métodos para tratamento e/ou prevenção de dor e de uma doença. | |
| RU2013111077A (ru) | Дипептидное пролекарство, его применение и лекарственное средство | |
| EA200600811A1 (ru) | НОВЫЕ ПРОИЗВОДНЫЕ ТЕТРАГИДРОСПИРО {ПИПЕРИДИН-2,7'-ПИРРОЛО [3,2-b]ПИРИДИНА} И НОВЫЕ ПРОИЗВОДНЫЕ ИНДОЛА, ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ РАССТРОЙСТВ, СВЯЗАННЫХ С 5-HT-РЕЦЕПТОРОМ | |
| RU2014111069A (ru) | Лекарственные формы ингибитора гистондиацетилазы в комбинации с бендамутином и их применение | |
| CY1111470T1 (el) | Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α | |
| CO5590918A2 (es) | Formulaciones | |
| MX2013003695A (es) | Combinaciones que contienen n-(2-arilamino) arilsulfonamida sustituida. | |
| RU2013127655A (ru) | Фармацевтическая комбинация паклитаксела и ингибитора cdk | |
| RU2011112684A (ru) | АГЕНТ, СПОСОБСТВУЮЩИЙ РОСТУ ВОЛОС, СОДЕРЖАЩИЙ В КАЧЕСТВЕ АКТИВНОГО ИНГРЕДИЕНТА ПРОИЗВОДНОЕ 15,15-ДИФТОРПРОСТАГЛАНДИНА F2α | |
| EA201071352A1 (ru) | Трициклические азотсодержащие соединения и их применение в качестве бактерицидных средств | |
| RU2010154417A (ru) | Комбинация частичного агониста никотиновых рецепторов и ингибитора ацетилхолинетеразы, содержащая ее фармацетическая композиция, и ее применение в лечении когнитивных расстройств | |
| RU2009128970A (ru) | Производные изосорбидмононитрата для лечения кишечных заболеваний | |
| RU2013107451A (ru) | Комбинация силоксана и активного ингредиента для лечения стоматологических заболеваний | |
| RU2010129038A (ru) | Соединения, предназначенные для лечения рака | |
| EA200600377A1 (ru) | Новая композиция | |
| RU2012106827A (ru) | Применение производных 5н-дибенз/в, f/азепин-5-карбоксамида для лечения фибромиалгии | |
| DK2091520T3 (da) | Oral doseringsform omfattende trisubstituerede glycerol-forbindelser | |
| DE602005017629D1 (de) | Pharmazeutische zusammensetzungen zur behandlung von leishmaniasis | |
| RU2008102912A (ru) | Сочетание ингибиторов бетта-лактазмы бициклического 6-алкилиденпенема с бетта-лактанным антибиотиком: антибиотик широкого спектра | |
| RU2011103778A (ru) | Противоопухолевые макролиды |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20151109 |